Please assess the completion status of the following clinical trial:

Trial Title: Safety Study Looking at the Effects of Stendra on Vision

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adult males 18 to 45 years of age, inclusive~* Non-tobacco user for at least 6 months prior to first dose~Exclusion Criteria:~* History or presence of retinal disease or any vision defects including color vision~* Intraocular pressure value ≥ 22mm Hg~* Resting heart rate \< 45 or \> 90 beats per minute (3 rechecks)~* Systolic blood pressure \< 90 or \> 140 mm Hg or Diastolic blood pressure \< 50 or \>90 mm Hg (3 rechecks)~* Initiation or change in dose of any α-blockers 14 days prior to randomization

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Active (Type: EXPERIMENTAL): Stendra 200 mg
- Placebo (Type: PLACEBO_COMPARATOR): placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).